BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 7340574)

  • 1. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease.
    Badylak SF; Dodds WJ; Van Vleet JF
    Am J Vet Res; 1983 Dec; 44(12):2336-40. PubMed ID: 6660623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation disorders in dogs with hepatic disease.
    Prins M; Schellens CJ; van Leeuwen MW; Rothuizen J; Teske E
    Vet J; 2010 Aug; 185(2):163-8. PubMed ID: 19487141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
    Mineo HK; Garabed RB
    Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F; Papasouliotis K; Crawford E; Dodkin S; Cue S
    Res Vet Sci; 2008 Aug; 85(1):166-70. PubMed ID: 17998140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
    Tseng LW; Hughes D; Giger U
    Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
    Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
    J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R; Nolte I
    Tierarztl Prax; 1991 Oct; 19(5):561-6. PubMed ID: 1759273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic abnormalities in cats with naturally occurring liver diseases.
    Dircks B; Nolte I; Mischke R
    Vet J; 2012 Jul; 193(1):103-8. PubMed ID: 22075256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective characterization of canine coagulopathies using the turbidimetric ACL-TOP 300 analyzer (2014-2015): Forty-seven dogs.
    Richardson R; Todd JM; Sharkey LC; Washabau RJ; Williams KD; Little KJ; Rendahl A
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):551-558. PubMed ID: 30320489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of prothrombin time measurements in canine plasma.
    Mischke R; Nolte I
    Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011).
    Song J; Drobatz KJ; Silverstein DC
    J Vet Emerg Crit Care (San Antonio); 2016 May; 26(3):398-405. PubMed ID: 27074596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of plasma coagulation tests and fibrinogen
    Enk NM; Kutter APN; Kuemmerle-Fraune C; Sigrist NE
    J Vet Intern Med; 2019 Jan; 33(1):132-140. PubMed ID: 30537199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation abnormalities associated with acute Angiostrongylus vasorum infection in dogs.
    Schelling CG; Greene CE; Prestwood AK; Tsang VC
    Am J Vet Res; 1986 Dec; 47(12):2669-73. PubMed ID: 3800129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated coagulation times in normal cats and dogs using MAX-ACT tubes.
    See AM; Swindells KL; Sharman MJ; Haack KL; Goodman D; Delaporta A; Robertson I; Foster SF
    Aust Vet J; 2009 Jul; 87(7):292-5. PubMed ID: 19573157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog.
    Center SA; Baldwin BH; Erb HN; Tennant BC
    J Am Vet Med Assoc; 1985 Nov; 187(9):935-40. PubMed ID: 4055519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.